Abacus Life, Inc. (NASDAQ:ABL) Position Increased by Gratia Capital LLC

Gratia Capital LLC grew its position in shares of Abacus Life, Inc. (NASDAQ:ABL) by 82.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 553,402 shares of the company’s stock after purchasing an additional 250,000 shares during the period. Abacus Life makes up about 4.3% of Gratia Capital LLC’s holdings, making the stock its 10th largest holding. Gratia Capital LLC’s holdings in Abacus Life were worth $4,333,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of ABL. Mendon Capital Advisors Corp boosted its stake in shares of Abacus Life by 137.1% in the fourth quarter. Mendon Capital Advisors Corp now owns 1,303,826 shares of the company’s stock valued at $10,209,000 after purchasing an additional 753,826 shares during the period. Curi RMB Capital LLC boosted its position in Abacus Life by 110.7% in the 4th quarter. Curi RMB Capital LLC now owns 1,159,000 shares of the company’s stock valued at $9,075,000 after buying an additional 609,000 shares during the period. Marshall Wace LLP acquired a new position in shares of Abacus Life in the fourth quarter worth $1,293,000. XTX Topco Ltd acquired a new position in shares of Abacus Life in the fourth quarter worth $193,000. Finally, Kennedy Capital Management LLC purchased a new stake in shares of Abacus Life during the fourth quarter worth $7,461,000.

Abacus Life Stock Performance

NASDAQ:ABL opened at $8.27 on Friday. Abacus Life, Inc. has a 12 month low of $6.34 and a 12 month high of $12.40. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a market capitalization of $800.97 million, a PE ratio of -45.94 and a beta of 0.16. The business’s fifty day moving average price is $7.58 and its 200 day moving average price is $7.94.

Abacus Life (NASDAQ:ABL) last released its quarterly earnings data on Thursday, March 27th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.03. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%. The business had revenue of $33.21 million for the quarter, compared to the consensus estimate of $28.76 million. On average, sell-side analysts anticipate that Abacus Life, Inc. will post 0.62 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently commented on the company. B. Riley lowered their target price on Abacus Life from $17.00 to $15.00 and set a “buy” rating for the company in a research note on Tuesday, January 7th. Piper Sandler decreased their price objective on Abacus Life from $13.00 to $11.50 and set an “overweight” rating for the company in a research note on Tuesday, April 8th. Five research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $14.00.

Abacus Life Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.